● Live Tracking 375+ pre-IPO companies with institutional-grade data — updated daily. 140 in active pipeline.

Ro IPO Status 2026

Direct-to-patient healthcare platform offering telemedicine, diagnostics, and pharmacy for chronic conditions.

IndustryHealthcare Technology
StageLate Stage / Pre-IPO
IPO StatusPrivate
Valuation$5B
Total Funding$1.1B
HeadquartersNew York, NY
CEOZachariah Reitano
How to Invest in Ro
Pre-IPO
🔔 Get Notified When Ro IPOs

No secondary market access for Ro yet. Get instant alerts when an S-1 is filed or IPO date is announced.

Get IPO Alerts →
📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
⚡Unlimited company analysis reports — all 375+ companies
✓Real-time IPO alerts — know the moment S-1s are filed
✓Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete Ro Analysis Brief
✓Executive summary & IPO readiness breakdown
✓Competitive positioning & funding trajectory
✓Bull / bear thesis with pricing projections
✓S-1 timeline estimate & risk assessment
$19
One-time
Secure checkout · Stripe · 24h delivery

Frequently Asked Questions

What is Ro's current valuation? +

Ro is valued at $5B as of the most recent funding round.

Has Ro filed for an IPO? +

Ro has filed an S-1 registration statement with the SEC on February 14, 2026, indicating an active IPO process.

How much total funding has Ro raised? +

Ro has raised $1.1B in total venture capital funding.

What sector is Ro in? +

Ro is a Healthcare Technology company. Direct-to-patient healthcare platform offering telemedicine, diagnostics, and pharmacy for chronic c.

What is Ro's IPO readiness score? +

Ro scores 75/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.